Skip to main content

Featured

Housing Market Outlook 2026: Prices Stabilizing, Demand Still Weak

  If you've been watching the Canadian housing market and waiting for a clear signal — up, down, or sideways — welcome to 2026, where the answer is stubbornly "sideways." Prices have stopped falling in most regions, but they're not exactly rallying either. Meanwhile, the buyers who were supposed to flood back after rate cuts? Still sitting on the fence. Here's what the data says and what it means for your wallet. 📊 Quick Stats — April 2026 National average home price: $695,412 (+2.2% year-over-year) National benchmark price (MLS HPI): $666,400 (-4.2% year-over-year) Months of inventory: 5.2 (balanced territory) GTA average price: $1,051,969 (-4.9% year-over-year) Bank of Canada policy rate: 2.25% (held steady) 📉 Why Are Prices "Stabilizing" But Not Recovering? Canada's housing market entered 2026 caught between two opposing forces. On one side, the Bank of Canada cut its policy rate from a peak of 5.0% all the way down to 2.25%, which should ...
Post a Comment
Read more

article

Labels

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Labels:

Comments

Post a Comment